Development of a guideline on the quality aspects of mRNA vaccines - Scientific guideline

Draft guideline on the quality aspects of mRNA vaccines

Draft Reflection paper on linking to electronic product information (ePI) from EU medicine packages

Human medicines European public assessment report (EPAR): Amgevita, adalimumab, Date of authorisation: 21/03/2017, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): MicardisPlus, Date of authorisation: 19/04/2002, Revision: 37, Status: Authorised

EVVet3 EVWeb Production - Release notes

List of centrally authorised products with safety-related changes to the product information

Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Date of authorisation: 21/02/2022, Revision: 2, Status: Lapsed

HMPC: overview of assessment work - priority list